FDA Approves Novavax COVID-19 Shot But With Unusual Restrictions

Article Summary

The Food and Drug Administration (FDA) has approved Novavax’s COVID-19 vaccine with unusual restrictions. Novavax’s vaccine is the nation’s only traditional protein-based coronavirus vaccine and it had previously received emergency authorization from the FDA. However, the recent approval comes with certain restrictions that make it unique.

What This Means for You

• Be aware of the FDA’s approval of Novavax’s COVID-19 vaccine and the unusual restrictions that come with it.
• Understand the difference between traditional protein-based vaccines and the mRNA vaccines currently in use.
• Consider the potential impact of this approval on vaccine hesitancy and public confidence in COVID-19 vaccines.
• Stay informed about future developments and potential changes to vaccine recommendations from public health authorities.

Original Post

%0A<!--%20RSS%20Ads%201%20--> %0A<ins%20class=" adsbygoogle style="display:block" data-ad-client="ca-pub-4072306711313981" data-ad-slot="8316424938" data-ad-format="auto" data-full-width-responsive="true"/>

ORIGINAL SOURCE:

Source link